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Abstract  
 
We examined the little-tested associations between general cognitive function in mid- to older-age 
and later risk of the chronic diseases.  In the English Longitudinal Study of Ageing (2002-12), 
11,391 study members, aged 50 to 100 years at study induction, were administered a battery of 
cognitive tests and provided a range of collateral data.  In an analytical sample of 9,204 people 
(4982 women), a mean duration of follow-up of 9.0 years gave rise to 1,488 deaths.  Using a 
summation of four cognition tests representing three acknowledged key domains of cognitive 
functioning (memory, executive function, processing speed), cognition was inversely associated 
with mortality rates ascribed to cancer (hazard ratios; 95% confidence interval per one standard 
deviation lower general cognitive function score:  1.21; 1.10, 1.33), cardiovascular disease (1.71; 
1.55, 1.89), ‘other’ causes (2.07; 1.79, 2.40), and respiratory illness (2.48; 2.12, 2.90).  Controlling 
for a range of covariates which included health behaviours and socioeconomic status, and left-
censoring to explore reverse causality, had very little impact on the strength of these relationships.  
These findings indicate that cognitive test scores can provide relatively simple indicators of 
mortality risk for an array of chronic diseases and these associations are independent of other 
commonly-assessed risk factors. 
 
Key words:  ageing, cancer, cardiovascular disease, cognitive function, mortality, respiratory illness 
Abbreviations:  ELSA, English Longitudinal Study of Ageing   
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Introduction 
Since the first-reported examination of a link between cognition and mortality risk over five 
decades ago,1 investigators using a series of cohort studies have shown that lower cognitive 
function measured in middle- and older-aged populations is associated with elevated rates of total 
mortality.2-8  These relationships do not appear to be ascribed to confounding by co-morbidity, 
socioeconomic status, or health behaviours, and are apparent not only in convenience samples but 
also general population-based groups. 
 
Aside from the occurrence of cardiovascular disease which has also been shown to be related to 
lower cognition,9-12 less well understood is the predictive value, if any, of cognitive function for 
other chronic diseases that comprise total mortality, including cancer and respiratory illness.  Those 
studies that have been conducted not only reveal discordant findings – for the two studies with all 
cancers as an outcome, for example, inverse13 and null3 associations with cognition are apparent – 
but methodological shortcomings also frequently hamper data interpretation.  These include the 
modest size of many studies which lead to endpoint rarity and the inability to explore gender-
specific effects and dose-response relationships.13  There is also a common focus on patient 
populations (e.g., people with diabetes14), so potentially restricting insights into the generalizability 
of findings.  It is also the case that the utilisation of crude clinical assessments which capture 
cognitive impairment (e.g., the Mini-Mental State Examination3;6) rather than the broader normal 
range of functioning, results in ‘ceiling effects’ (the majority of subjects score highly on a test so 
reducing discrimination), and offer no information about different intellectual domains.   
 
The English Longitudinal Study of Ageing (ELSA) is a large-scale prospective cohort study of the 
general population whose more than 11,000 members were administered a battery of cognitive tests 
at baseline and have provided a range of collateral data.15  Now in its 10th year of mortality 
surveillance, the study population has matured to the point where a high number of deaths have 
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accumulated to facilitate analyses of the little-tested relation of cognitive function with causes of 
death other than cardiovascular disease.     
  
Methods 
Data were taken from ELSA, an on-going, representative, prospective cohort study of older, non-
institutionalised men and women in England.15  The cohort is based on individuals of 50 years of 
age or older who took part in one of three cross-sectional studies that comprise the Health Surveys 
for England (1998, 1999, and 2001).16  The first active phase of data collection in ELSA took place 
in 2002-03 when 11,391 men and women participated.15  Comparisons of the socio-demographic 
characteristics of participants against results from the national census indicate that the sample was 
broadly representative of the English population.15  Over the last decade years there have been six 
biennial face-to-face examinations of study members.  For the purposes of the present analyses, our 
‘baseline’ is the first wave of data collection in ELSA in 2002-03.  Participants gave their informed 
consent to take part in the study, and ethical approval was granted by the London multicentre 
research ethics committee. 
 
Measurement of cognitive function 
Cognitive function was assessed using a battery of tests.15  For the purposes of the present analyses, 
we selected four measures comprising three acknowledged key domains of cognitive functioning:  
memory, processing speed, and executive function.  Memory was measured using the word-list 
learning test in which ten words were presented orally to study participants who were then asked to 
recall as many as possible immediately after the reading, and then again after an approximately five 
minute delay during which they completed other survey questions.  We computed an overall 
memory score (range: 0 to 20) using both the immediate and delayed recall (between-test 
correlation coefficient: 0.70).  Executive function was ascertained using a word finding task 
(semantic verbal fluency), a test of how quickly participants can name as many different animals as 
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possible in one minute (score range:  0 to 60).  Processing speed was measured using a letter 
cancellation test.  The participant was handed a page of randomly generated letters of the alphabet 
set out in rows and columns with the request that they cross out as many of the target letters (‘P’ 
and ‘W’) as possible within one minute.  The total number of letters searched provides a measure of 
speed of processing (range: 0 to 64).  All scores are normally distributed with no evidence of floor 
and ceiling effect.  The cognitive function module in ELSA also included the following four tests: 
self-rated memory, orientation in time (day, month and year), prospective memory (remembering to 
carry out some actions during the clinical examination), and numerical ability (three simple 
problems requiring numerical calculations).   A priori, we elected not to use these tests for the 
following reasons.  Two tests were not capable of discriminating across the cognitive function range 
(ceiling effects were apparent) owing to overly simple questions with few response options 
(orientation in time test) or, indeed, having only two response options (prospective memory test).  
One additional test captured educational performance rather than cognitive function (numerical 
ability test).  The final ‘test’ was not actually a cognitive test and, lacking a correlation with the 
validated cognitive tests, showed poor concurrent validity (self-rated memory test).  It is also the 
case that these omitted tests do not represent new cognitive domains relative to those already 
featured in our analyses.   
 
Covariate data 
Self-reported health behaviours included smoking status (current, ex-smokers , and never),  
frequency of alcohol consumption in the past year (daily/almost daily, 1–2 times/week, 1–2 
times/month, never/almost never), and physical activity (medium and high physical activity were 
denoted by vigorous or moderate intensity exertion at least once per week; all other activity was 
recorded as low).  Major illness at wave 1 was denoted by a self-report of physician diagnosis of 
diabetes, cancer, or coronary heart disease.  Enquiries were also made concerning any difficulties 
study members may have experienced in carrying out six activities of daily living (e.g., dressing, 
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bathing, using the toilet) and seven instrumental activities of daily living (e.g. taking medications, 
preparing a hot meal).  Participants reporting one or more difficulty for at least three months in each 
domain were classified as having an impairment.    
 
We measured depressive symptoms using the eight-item Center for Epidemiological Studies-
Depression scale, a widely used self-report device to identify people at risk of depression in 
population studies.  Finally, body mass index (kg/m2) was computed from height and weight data 
collected during a home visit as part of the Health Survey for England (1998-2001).  We used three 
indicators of socioeconomic status, selected to capture the life course of study members.  Paternal 
occupational social class was used as an indicator of social status and divided into three levels (high 
[e.g., managerial], intermediate [e.g., trade- and services-related job], and low [e.g., manual/casual 
job; unemployed]).  Subject’s own educational attainment was used as a marker of interim social 
position and, again, categorised into three groups (high [e.g., university degree or higher], 
intermediate [e.g., ordinary or advanced level secondary school examinations, or equivalent], and 
low [compulsory school leaving]).  Wealth, which was based on age-adjusted quintiles for the 
purposes of analysis, was measured according to total household wealth, including financial wealth 
(savings and investments), the value of any home and other property (less mortgage), the value of 
any business assets, and physical wealth such as artwork and jewelry, net of debt.     
 
Mortality ascertainment 
Study members were linked to the National Health Service’s Central Registry at Southport UK, the 
procedures of which provide vital status data.  Owing to reasons of anonymity, cause of death data 
are provided for board classifications of disease according to International Classification of Disease 
chapters (version 10):17 cardiovascular disease (I00-I99), cancer (C00-C97), respiratory disease 
(J00-J99)), and ‘other [remaining] causes’.  Follow-up began on the date of study induction 
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(2002/3) with study members censored at date of death, or end of follow-up (March 2012) – 
whichever came first.  
 
Statistical Analyses 
From a starting sample of 11,391 individuals at study induction (figure 1), exclusions owing to a 
failure to consent to linkage to death data, and missing data on cognitive function, covariates or 
cause of death, resulted in an analytical sample of 9,204 people (4,982 women).  In this group the 
magnitude of the correlation between each of the three domains of cognitive function were 
moderate (spearman correlation coefficient range: 0.33 to 0.46).  Cognitive function in each domain 
also revealed a similar pattern of association with the five mortality outcomes (web tables 1-3).  
This observation supports others in the field of cognitive epidemiology where, in general, individual 
cognitive domains are not found to be better predictors of disease outcomes than a more general 
cognitive score.  On this basis, and in the interests of brevity of presentation, we utilized total 
cognitive function as our main exposure (hereafter referred to as general cognitive function) by 
summing results from the three intellectual domains (range: 0 to 144).   
 
---insert figure 1--- 
 
Having ascertained that the proportional hazards assumption had not been violated, to summarise 
the relationship between cognitive function and mortality rates we used the Cox model18 to compute 
hazard ratios with accompanying 95% confidence intervals.  With both cognition and mortality 
rates being strongly patterned by age, we explored the impact on our results of using two different 
time scales: calendar time (with adjustment for age) and age itself.  With both approaches producing 
near-identical results, our Cox model was set with calendar time as the time scale.   As there was no 
evidence of differential cognition–mortality relationship in men and women, data were pooled and 
gender-adjusted.  We used a series of multivariable models that were designed to assess the impact, 
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if any, of controlling for a range of covariates organised by theme (e.g., health behaviours [physical 
activity, smoking, alcohol intake], socioeconomic status [parental social class, educational 
attainment, wealth], and so on).   
 
Results 
In table 1 we show study member baseline characteristics according to quintiles of general 
cognition function.  As anticipated, lower cognitive function was apparent in study members who 
were older, had more physical and psychological co-morbidities (diabetes, cancer, heart disease, 
depression), and, to a moderate extent, those who smoked.  An impairment in carrying  out 
activities of daily living, including those instrumental to self-care, were around three times more 
common in the lower cognition group relative to the highest performers.  Similarly strongly related 
to cognition were the markers of social circumstances, such that lower social class of origin, a more 
basic education, and reduced wealth index were all strongly patterned by general cognitive function.   
 
---insert table 1--- 
 
In an analytical sample of 9,204 people (4982 women), a mean duration of follow-up of 9.0 years 
(standard deviation 2.3) gave rise to 1,476 deaths, comprising 517 from cardiovascular disease, 509 
from cancer, 210 from respiratory causes, and 240 from other causes (largely made up of external 
causes of death).   In table 2 we depict the relation of a standard deviation lower cognitive function 
score with the five mortality endpoints.  When the rate of total mortality was the outcome of 
interest, in age- and sex-adjusted analyses, a one standard deviation lower score on general 
cognitive function was associated with 64% elevated risk of death.  Adding groups of covariates by 
theme separately to the model resulted in only modest attenuation with no particular set having a 
greater impact that another.   
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---insert table 2--- 
 
In analyses featuring specific classifications of cause death, there was again evidence of an inverse 
association with general cognition such that a higher mortality risk was seen across all outcomes in 
people who had lower cognition scores.  There was, however, evidence of heterogeneity whereby 
the weakest association was seen for deaths from cancer of all sites combined (age- and sex-
adjusted hazard ratio; 95% confidence interval: 1.21; 1.10, 1.33) and the strongest for respiratory 
disease (2.48; 2.12, 2.90); relationships of intermediate magnitude were apparent for cardiovascular 
disease (1.71; 1.55; 1.89) and ‘other’ causes (2.07; 1.79; 2.40).  As per the analyses of total 
mortality, hazard ratios for cognitive function and these disease categories were largely robust to 
the adjustment of an array of potential covariates.   
 
We conducted a series of planned sub-group analyses to scrutinise these general cognition–death 
relationships further.  Given its correlation with cognitive function (r=0.3, p-value<0.001), having 
education in a multivariable model raises concerns regarding co-linearity.  Therefore , we computed 
hazard ratio in a multiply-adjusted model with and without the presence of education and there was 
essentially no difference (results available upon request).  Also, undetected physical co-morbidity, 
particularly in an elderly population, is likely to be commonplace, raising short-term mortality risk 
and possibly lowering cognitive function and so potentially generating a spurious cognition–death 
relationship.  To explore this potential for reverse causality, we excluded from our analyses deaths 
occurring in the first year of follow-up (‘left-censoring’), reasoning that these might be apportioned 
to such hidden co-morbidity.  Taking this approach did not produce any discernible impact on the 
magnitude of our hazard ratios (results available upon request).     
 
Hitherto, we have presented the relations of cognition with mortality rates according to a one 
standard deviation change in the exposure.  In order to provide insight into the ‘shape’ of the 
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association (e.g., threshold versus dose-response effects), in figure 2 we show the risk of mortality 
from each cause across the full range of general cognition scores (deciles of cognition in analyses of 
total mortality rates; quintiles for the other endpoints owing to smaller numbers).  For the risk of 
total mortality there was a clear stepwise associations with cognition (p[trend] = <0.001), such that 
study participants in the highest decile of cognition had around one third of  the risk of those in the 
lowest.  Stronger cognition–mortality risk gradients were apparent for categories of death where 
people in the highest fifth of general cognition scores experienced around one fifth (cardiovascular 
disease [figure 3A], other [figure 3D]) or one tenth (respiratory [figure 3C]) of the risk relative to 
those in the lowest quintile.  Although higher cognitive function was associated with a somewhat 
lower risk of all malignancies combined (figure 3B), no trend was seen.  
 
---insert figures 2 and 3--- 
 
Discussion 
The main finding of the present study was that, in addition to being related to elevated rates of total 
mortality and cardiovascular disease, lower general cognitive function assessed between the ages of 
50 and 100 years was also associated with an elevated risk of death ascribed to cancer and 
respiratory disease.  Whereas the strength of these relationships differed according to the endpoint 
in question, controlling for a range of covariates had modest impact, as did left-censoring in an 
effort to explore reverse causality owing to occult disease.  These findings indicate that cognitive 
test scores can provide simple indicators of risk for an array of chronic diseases and these 
associations are independent of other commonly-assessed risk factors.  With the evidence that 
cognitive decline in older groups may be slowed,19 our findings have potential public health 
significance.  
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Comparison with other studies of cognition and chronic disease 
Our findings closely accord with those seen in other studies of cognition in middle- and older-age in 
relation to all-cause mortality rates2-7 and cardiovascular disease9-12 where inverse associations are 
consistently reported.  For cancer deaths which, as discussed, has been little related to cognition, 
there are very few relevant studies and what findings exist are discrepant.  Thus, whereas one study 
found a null effect,3 an apparently protective association of higher cognition was evident in a 
smaller-scale investigation.13  Reaction time, a measure of information processing speed, has also 
been related to cancer risk in general population-based cohort studies with null results apparent for 
both all malignancies combined20 and site-specific presentations.21  The predictive role for 
cognition in relation to respiratory disease is less well examined still:  in the only study of a 
middle/older aged group of which we are aware, there was no apparent link.3   
 
Potential mechanisms 
That the cognition-death relationships reported here were not heavily confounded nor explained by 
reverse causality raises questions as to the potential mechanisms involved.  Although it is likely that 
the relations of cognition with categories of death will be ascribed to specific mechanisms – a 
biomedical model encompassing vascular changes would seem to have little relevance for 
malignancy, for instance – some general explanations may be advanced.  First, health literacy, 
which concerns the skills required to gain access to and synthesise health information is often 
advanced in this regard, not least because it is directly related to cognitive function.22  Similarly, 
people with lower cognitive function scores are also less likely to seek preventative advice when 
disease-free, and, when illness does occur, recognize symptoms, seek medical care, and comply 
with treatment.6  It is therefore possible that health literacy, as it often tends to be assessed, does 
little more by way of explanation than providing an alternative assessment of cognition, adding 
little to cognitive ability in accounting for disease variance.23;24  A second possibility is the system 
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integrity explanation which posits that higher cognition may be a marker for a superior body 
functioning body.25  That is, higher cognition might be a characteristic of a “well-wired” physiology 
that responds more robustly to common environmental insults.  However, given that the participants 
were already in middle-age or older at the baseline cognitive testing session, and that system 
integrity refers to cognitive and bodily state in youth, it is more likely that the lower cognition and 
poorer health could be due to some set of ageing-related common causes that affect both health and 
cognition.22 
 
Strengths and limitations 
Whereas ELSA has a number of strengths over many other ageing studies – its higher resolution 
cognitive function measurement for a large scale investigation, the generalizability of findings from 
a geographically representative sample, and the large number of deaths – it has some limitations.  
First, in the interests on anonymity, not being provided with specific cause of death for deceased 
study members, including individual presentations of  cardiovascular disease phenotypes (stroke, 
peripheral vascular disease, heart failure) cancer (breast, colorectal) is a drawback.  Second, with 
mortality comprising both disease incidence and survival, a cognition–mortality relation may, in 
part, be due to the choice of medical treatment in study members with diagnosed illness.  To the 
best of our knowledge, there are no studies of cognition and treatment choice.  To explore this issue 
for major chronic diseases such as cancer and cardiovascular disease in the present study we would 
need to examine the association between cognition and treatment choice for the same severity of 
illness (e.g., cancer stage) as treatments options differ by severity.  Unfortunately, we do not have 
these data.  An alternative approach would be to use disease incidence as the outcome of interest to 
ascertain if the relation with cognition differs relative to the results for mortality.  Again, however, 
we do not have these data in ELSA.  In a study which examined the predictive value of a range of 
established risk factors for both morbidity (hospital records) and mortality ascribed to 
cerebrovascular disease, similar relationships were seen irrespective of how the outcome was 
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ascertained.26  We are unaware of any such studies in which the exposure was cognition, however.   
Third, diet, in keeping with other behaviours, appears to be under a degree of cognitive control,27;28 
and is itself related to some of the mortality outcomes features herein.  However, we had no such 
detailed data on diet to allow us to explore their potential confounding or mediating effects.  Fourth, 
having cognition scores from an older-aged group means that the inverse associations with 
mortality rates could be at least be partly generated by undetected disease at study induction, 
resulting in both lower cognitive function29;30 and elevated mortality risk.  While our hazard ratios 
did not appear to be sensitive to left-censoring – a standard procedure for exploring reverse 
causality – an alternative approach is to utilise scores from early in adulthood or youth where 
chronic disease is rare and therefore of little potential influence on cognition.31-33  With ELSA 
having been initiated in middle/older-age, no such data are available.  Lastly, while participants in 
ELSA are generally well-characterised, so allowing us to adjust our effect estimates for a range of 
covariates, there is inevitably a problem of residual confounding that is common to all observational 
studies.  Thus, either some potential covariates were unmeasured at study baseline (e.g., markers of 
systemic inflammation) or may not have been captured fully (e.g., severity of disease).   
 
In conclusion, in the present study, in addition to mortality from all causes and cardiovascular 
disease, lower cognitive function was related to the risk of cancer and respiratory illness risk.  These 
findings indicate that cognitive test scores can provide simple indicators of mortality risk for an 
array of chronic diseases and this is independent of other commonly-assessed risk factors. 
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Table 1.  Baseline characteristics of study members according to general cognitive function quintile –  
The English Longitudinal Study of Ageing, 2002–2012 (N=9,204) 
 
 Cognitive function quintilea  
 1 
(n = 1,902) 
2 
(1,889) 
3 
(1,940) 
4 
(1,697) 
5 
(1,776) 
 
 Mean 
(SD) 
% Mean 
(SD) 
% Mean 
(SD) 
% Mean 
(SD) 
% Mean 
(SD) 
%  
            
Cognition score 31.4 (5.9)  42.2 (2.0)  48.5 (1.7)  54.3 (1.7)  64.4 (6.2)   
Age 69.8 (10.5)  65.2 (9.4)  62.8 (8.8)  60.7 (7.8)  59.1 (7.5)  <0.001 
Male  49.1  48.5  46.0  43.5  41.7 <0.001 
Low physical activity  49.4  31.6  25.1  20.8  18.9 <0.001 
Current smoker  18.6  18.3  19.0  17.0  17.6 <0.001 
Alcohol intake daily/almost daily  21.8  28.7  26.4  30.9  35.1 <0.001 
Body mass index (kg/m2) 27.6 (4.4)  27.8 (4.7)  27.6 (4.5)  27.7 (4.6)  27.3 (4.6)  <0.05 
Diabetes  11.3  7.5  6.6  4.8  4.1 <0.001 
Cancer  7.1  7.0  5.3  6.2  5.1 <0.05 
Coronary heart disease  21.0  14.1  10.7  8.5  6.3 <0.001 
Depressive symptoms 2.1 (2.2)  1.6 (2.0)  1.4 (1.8)  1.2 (1.7)  1.2 (1.7)  <0.001 
Impaired activities of daily living  30.1  20.6  15.0  14.7  11.0 <0.001 
Impaired instrumental activities of daily 
living 
 32.0  20.4  15.8  13.6  10.6 <0.001 
Lowest quintile of wealth  32.2  19.6  14.1  11.8  9.2 <0.001 
Low parental social class  48.1  42.8  36.7  35.5  29.3 <0.001 
Low education  70.7  62.9  53.8  44.6  31.8 <0.001 
 
a1 (lowest, ≤ 38); 2 (39-45); 3 (46-51); 4 (52-57); 5 (58-103).     
bP-value for trend for dichotomous and continuous measures; otherwise, p-value for heterogeneity.   
SD, standard deviation 
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Table 2.  Hazard ratios (95% CI) for the relation of a one standard deviation disadvantage (lower) in general cognitive function with 
total and cause-specific mortality rates – English Longitudinal Study of Ageing, 2002–2012 (N=9204) 
 
 
 All-cause 
(n = 1,476) 
CVD 
(517) 
Cancer 
(509) 
Respiratory illness 
(210) 
Other causes 
(240) 
Adjustments HR 95% CI HR 95% CI HR 95% CI HR 95% CI  95% CI 
           
Age + sex 1.64 1.54, 1.74 1.71 1.55, 1.89 1.21 1.10, 1.33 2.48 2.12, 2.90 2.07 
 
1.79, 2.40 
Age, sex  + health behavioursa 1.53 
 
1.44, 1.63 1.60 
 
1.45, 1.77 1.15 
 
1.04, 1.27 2.20 
 
1.88, 2.58 1.94 
 
1.67, 2.26 
Age, sex  + existing illnessb 1.57 
 
1.48, 1.67 1.64 
 
1.48, 1.82 1.18 
 
1.07, 1.31 2.31 
 
1.97, 2.71 1.97 
 
1.70, 2.29 
Age, sex  + physical functionc 1.53 
 
1.44, 1.62 1.58 
 
1.43, 1.75 1.17 
 
1.06, 1.29 2.24 
 
1.91, 2.63 1.90 
 
1.64, 2.21 
Age, sex  + socioeconomic statusd 1.56 
 
1.47, 1.66 1.62 
 
1.46, 1.79 1.19 
 
1.07, 1.31 2.26 
 
1.92, 2.65 2.00 
 
1.71, 2.33 
Fully adjustede 1.45 
 
1.36, 1.54 1.49 
 
1.35, 1.66 1.13 
 
1.02, 1.26 1.97 
 
1.67, 2.33 1.81 
 
1.55, 2.12 
 
aHealth behaviours is denoted by: physical activity, cigarette smoking, alcohol intake, body mass index.  
bExisting illness is denoted by: self-reported physician diagnosed diabetes, cancer, and coronary heart disease, and depression score. 
cSocioeconomic status is denoted by: adult wealth and parental occupational social class.   
dPhysical function is denoted by:  number of limitations with activities of daily living and instrumental activities of daily living. 
eFull adjustment is adjustment for all above covariates. 
CVD, cardiovascular disease. 
HR, hazard ratio 
CI, confidence interval 
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Web Table 1.  Hazard ratios (95% CI) for the relation of a one SD disadvantage (lower) in memoryf score with category-specific mortality – 
English Longitudinal Study of Ageing, 2002–2012 (N=9204) 
  
 All-cause 
(n = 1,476) 
CVD 
(517) 
Cancer 
(509) 
Respiratory illness 
(210) 
Other causes 
(240) 
Adjustments HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
           
Age + sex 1.47 
 
1.39, 1.56 1.61 
 
1.46, 1.77 1.08 
 
0.98, 1.19 1.97 
 
1.70, 2.30 1.94 
 
1.68, 2.24 
Age, sex  + health behavioursa 1.40 
 
1.33, 1.49 1.53 
 
1.39, 1.69 1.04 
 
0.95, 1.15 1.82 
 
1.56, 2.12 1.85 
 
1.60, 2.13 
Age, sex  + existing illnessb 1.41 
 
1.34, 1.50 1.53 
 
1.39, 1.69 1.05 
 
0.96, 1.16 1.86 
 
1.59, 2.16 1.86 
 
1.61, 2.15 
Age, sex  + physical functionc 1.40 
 
1.32, 1.48 1.51 
 
1.37, 1.66 1.05 
 
0.96, 1.16 1.81 
 
1.55, 2.11 1.81 
 
1.57, 2.10 
Age, sex  + socioeconomic statusd 1.41 
 
1.33, 1.49 1.53 
 
1.39, 1.69 1.05 
 
0.96, 1.16 1.83 
 
1.56, 2.14 1.87 
 
1.61, 2.16 
Fully adjustede 1.33 
 
1.25, 1.41 1.43 
 
1.30, 1.58 1.01 
 
0.92, 1.12 1.67 
 
1.42, 1.95 1.74 
 
1.51, 2.02 
 
 
aHealth behaviours is denoted by: physical activity, cigarette smoking, alcohol intake, body mass index.  
bExisting illness is denoted by: self-reported physician diagnosed diabetes, cancer, and coronary heart disease, and depression score. 
cSocioeconomic status is denoted by: adult wealth and parental occupational social class.   
dPhysical function is denoted by:  number of limitations with activities of daily living and instrumental activities of daily living. 
eFull adjustment is adjustment for all above covariates. 
fMemory was measured using a word-list learning task. 
CVD, cardiovascular disease. 
HR, hazard ratio 
CI, confidence interval 
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Web Table 2.  Hazard ratios (95% CI) for the relation of a one SD disadvantage (lower) in executive functionf score with category-specific 
mortality – English Longitudinal Study of Ageing, 2002–2012 (N=9204) 
 
 All-cause 
(n = 1,476) 
CVD 
(517) 
Cancer 
(509) 
Respiratory illness 
(210) 
Other causes 
(240) 
Adjustments HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
           
Age + sex 1.37 
 
1.29, 1.45 1.37 
 
1.24, 1.51 1.14 
 
1.03, 1.25 1.82 
 
1.55, 2.13 1.64 
 
1.41, 1.90 
Age, sex  + health behavioursa 1.29 
 
1.22, 1.37 1.29 
 
1.17, 1.43 1.09 
 
0.99, 1.21 1.64 
 
1.40, 1.92 1.54 
 
1.32, 1.79 
Age, sex  + existing illnessb 1.32 
 
1.25, 1.40 1.31 
 
1.19, 1.45 1.13 
 
1.02, 1.25 1.70 
 
1.45, 1.99 1.56 
 
1.34, 1.82 
Age, sex  + physical functionc 1.29 
 
1.21, 1.37 1.27 
 
1.15, 1.41 1.11 
 
1.01, 1.22 1.66 
 
1.42, 1.95 1.52 
 
1.30, 1.77 
Age, sex  + socioeconomic statusd 1.30 
 
1.22, 1.38 1.28 
 
1.16, 1.42 1.11 
 
1.01, 1.23 1.65 
 
1.40, 1.94 1.56 
 
1.34, 1.82 
Fully adjustede 1.23 
 
1.15, 1.30 1.21 
 
1.09, 1.34 1.09 
 
0.99, 1.20 1.47 
 
1.25, 1.73 1.44 
 
1.23, 1.69 
 
aHealth behaviours is denoted by: physical activity, cigarette smoking, alcohol intake, body mass index.  
bExisting illness is denoted by: self-reported physician diagnosed diabetes, cancer, and coronary heart disease, and depression score. 
cSocioeconomic status is denoted by: adult wealth and parental occupational social class.   
dPhysical function is denoted by:  number of limitations with activities of daily living and instrumental activities of daily living. 
eFull adjustment is adjustment for all above covariates. 
fExecutive function was measured using a word finding task. 
CVD, cardiovascular disease. 
HR, hazard ratio 
CI, confidence interval 
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Web Table 3.  Hazard ratios (95% CI) for the relation of a one SD disadvantage (lower) in processing speedf score with category-specific 
mortality – English Longitudinal Study of Ageing, 2002–2012 (N=9204) 
 
 All-cause 
(n = 1,476) 
CVD 
(517) 
Cancer 
(509) 
Respiratory illness 
(210) 
Other causes 
(240) 
Adjustments HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
           
Age + sex 
 
1.50 1.41, 1.59 1.56 1.41, 1.73 1.20 1.09, 1.32 2.18 1.85, 2.56 1.69 1.46, 1.97 
Age, sex  + health behavioursa 
 
1.43 1.34, 1.51 1.48 1.33, 1.63 1.16 1.05, 1.28 2.01 1.70, 2.37 1.60 1.38, 1.86 
Age, sex  + existing illnessb 
 
1.45 1.37, 1.54 1.52 1.37, 1.69 1.17 1.06, 1.29 2.07 1.75, 2.45 1.63 1.40, 1.89 
Age, sex  + physical functionc 
 
1.41 1.33, 1.50 1.46 1.32, 1.62 1.17 1.06, 1.29 1.99 1.69, 2.34 1.57 1.35, 1.82 
Age, sex  + socioeconomic statusd 
 
1.44 1.36, 1.53 1.49 1.34, 1.65 1.18 1.07, 1.31 2.00 1.69, 2.36 1.61 1.39, 1.88 
Fully adjustede 
 
1.35 1.27, 1.44 1.40 1.26, 1.55 1.13 1.03, 1.25 1.82 1.54, 2.16 1.49 1.28, 1.74 
 
 
aHealth behaviours is denoted by: physical activity, cigarette smoking, alcohol intake, body mass index.  
bExisting illness is denoted by: self-reported physician diagnosed diabetes, cancer, and coronary heart disease, and depression score. 
cSocioeconomic status is denoted by: adult wealth and parental occupational social class.   
dPhysical function is denoted by:  number of limitations with activities of daily living and instrumental activities of daily living. 
eFull adjustment is adjustment for all above covariates. 
fExecutive function was measured using a word finding task. 
CVD, cardiovascular disease. 
HR, hazard ratio 
CI, confidence interval 
fProcessing speed was measured using a letter cancellation test.   
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Figure 1.  Numbers of study members from induction through to analytic sample:  
the English Longitudinal Study of Ageing, 2002–2012 
 
 
 
 
 
 
Figure 2.  Hazard ratios for the association of general cognitive function scores  
with total mortality rates – English Longitudinal Study of Ageing (N=9,204), 2002–2012 
 
Higher deciles represent higher cognitive function scores 
 
Hazard ratios are fully adjusted as per covariates in table 3.  Errors bars are 95% confidence 
intervals. 
 
 
 
 
 
Figure 3.  Hazard ratios for the association of general cognitive function scores with 
category-specific mortality rates – English Longitudinal Study of Ageing (N=9,204), 2002–
2012 
 
 
A, Cardiovascular disease deaths (p-value for trend <0.001); B, All cancer deaths (p-value for trend 
0.141); C, Respiratory deaths (p-value for trend <0.001); D, Other causes of death (p-value for trend 
<0.001) 
 
Higher quartiles represent higher cognitive function scores 
 
Hazard ratios are fully adjusted as per covariates in table 3.  Errors bars are 95% confidence 
intervals. 
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